Posts Tagged ‘laropiprant’

RSS

July 21st, 2014

Selections from Richard Lehman’s Literature Review: July 21st

This week’s topics include the effects of extended-release niacin with laropiprant in high-risk patients and dual-antiplatelet beyond one year after DES implantation.


January 15th, 2013

Is HDL Fool’s Gold?

Peter P. Toth offers his perspective on recent trials of niacin, including HPS2-THRIVE and AIM-HIGH.